Verastem Oncology
VSTM
#7655
Rank
C$0.37 B
Marketcap
$7.33
Share price
-9.47%
Change (1 day)
-54.73%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -C$0.19 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are C$10 Million. a decrease over its 2023 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.19 Billion49.31%
2023 -C$0.13 Billion18.36%
2022 -C$0.11 Billion3.67%
2021 -C$0.11 Billion5.43%
2020 -C$95.99 Million-54.74%
2019 -C$0.22 Billion105.99%
2018 -C$0.11 Billion6.83%
2017 -C$96.37 Million86.06%
2016 -C$51.8 Million-37.03%
2015 -C$82.25 Million8.43%
2014 -C$75.85 Million29.52%
2013 -C$58.56 Million28.6%
2012 -C$45.54 Million133.9%
2011 -C$19.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$63.69 Million-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.79 B-8,618.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.65 B-995.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.24 B-3,468.70%๐Ÿ‡ฌ๐Ÿ‡ง UK